Cargando…

Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes

BACKGROUND: Acquired or immune-mediated TTP (iTTP) is a life-threatening thrombotic microangiopathy, characterized by the presence of microangiopathic hemolytic anemia and severe thrombocytopenia, and a variable degree of ischemic organ damage, related to a severe deficiency of ADAMTS13, which is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kucukyurt, Selin, Eskazan, Ahmet Emre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532071/ https://www.ncbi.nlm.nih.gov/pubmed/33061729 http://dx.doi.org/10.2147/JBM.S205630

Ejemplares similares

Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020)

Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase
por: Westwood, John Paul, et al.
Publicado: (2022)

Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection
por: Fang, Fei, et al.
Publicado: (2022)

P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY
por: Rubia, Javier DE LA, et al.
Publicado: (2023)

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)
por: King, Jeanelle, et al.
Publicado: (2017)

P1608: REAL-WORLD INSIGHTS ON THE MANAGEMENT OF IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP) WITH CAPLACIZUMAB IN BELGIUM
por: Dierickx, Daan, et al.
Publicado: (2023)

Unresponsive Thrombotic Thrombocytopenic Purpura (TTP): Challenges and Solutions
por: Lemiale, Virginie, et al.
Publicado: (2021)

Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
por: Elverdi, Tugrul, et al.
Publicado: (2019)

Tacrolimus associated thrombotic thrombocytopenic purpura (TTP) and stroke in the young
por: Maramattom, Boby Varkey, et al.
Publicado: (2015)

Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era
por: Louw, Susan, et al.
Publicado: (2018)

Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19
por: Albiol, Nil, et al.
Publicado: (2020)

Caplacizumab as frontline therapy in addition to standard treatment in iTTP
por: Cid, Joan, et al.
Publicado: (2022)

Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023
por: Matsumoto, Masanori, et al.
Publicado: (2023)

Case of juvenile dermatomyositis (JDM), thrombotic thrombocytopenic purpura (TTP), and Purtscher retinopathy
por: Goldzweig, Ofra, et al.
Publicado: (2012)

Severe Thrombotic Thrombocytopenic Purpura (TTP) with Organ Failure in Critically Ill Patients
por: Fodil, Sofiane, et al.
Publicado: (2022)

PB2304: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP): A SINGLE-CENTER EXPERIENCE
por: Kammoun, F., et al.
Publicado: (2022)

COVID‐19‐induced thrombotic microangiopathy: A great mimicker of thrombotic thrombocytopenic purpura (TTP)
por: Warnecke, Brian, et al.
Publicado: (2023)

LATE-ONSET IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AFTER ASYMPTOMATIC COVID-19 INFECTION
por: SALUJA, PRACHI, et al.
Publicado: (2022)

Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature
por: Al-Husban, Naser, et al.
Publicado: (2018)

Successful Treatment of Refractory Thrombotic Thrombocytopenic Purpura (TTP) With Caplacizumab: A Case Report
por: Pramanik, Debolina, et al.
Publicado: (2023)

Global Health Resource Utilization and Cost-Effectiveness of Therapeutics and Diagnostics in Immune Thrombotic Thrombocytopenic Purpura (TTP)
por: Butt, Ayesha, et al.
Publicado: (2023)

COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review
por: Tehrani, Hamed Azhdari, et al.
Publicado: (2021)

Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination
por: Francisco, Michael T., et al.
Publicado: (2021)

HIV‐associated thrombotic thrombocytopenic purpura (HIV‐TTP): A practical guide and review of the literature
por: Louw, Susan, et al.
Publicado: (2022)

P1605: IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA IN OLDER PATIENTS: RESULTS FROM THE SPANISH TTP REGISTRY (REPTT)
por: Seguí, Inés Gómez, et al.
Publicado: (2023)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP
por: De Waele, Laure, et al.
Publicado: (2021)

Thrombotic Thrombocytopenic Purpura (TTP)–Like Illness Associated with Intravenous Opana ER Abuse — Tennessee, 2012
por: Marder, Ellyn, et al.
Publicado: (2013)

Congenital thrombotic thrombocytopenic purpura (TTP) with placental abruption despite maternal improvement: a case report
por: Soffer, Marti D., et al.
Publicado: (2020)

Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases
por: Saluja, Prachi, et al.
Publicado: (2022)

Thrombotic microangiopathy (aHUS/iTTP) reported so far in Covid-19 patients: The virus alone or an omnium gatherum of mechanisms and etiologies?
por: Mir, Tajamul H.
Publicado: (2021)

Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)

The perfect storm: Thrombotic thrombocytopenic purpura (TTP) associated with COVID‐19, a clinical case series and review
por: Melissa, Neumann, et al.
Publicado: (2022)

A Rare Case of Thrombotic Thrombocytopenic Purpura (TTP) With Concurrent Renal Cell Carcinoma: Diagnostic and Therapeutic Challenges
por: Bhandari, Amit, et al.
Publicado: (2023)

Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience
por: Öngören, Seniz, et al.
Publicado: (2018)

COVID-19-ASSOCIATED THROMBOTIC THROMBOCYTOPENIA PURPURA (TTP)
por: JAIN, HANISH, et al.
Publicado: (2022)

Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura
por: Bae, Sung Hwa, et al.
Publicado: (2022)

Preemptive cyclosporin A in immune‐mediated thrombotic thrombocytopenic purpura
por: Comparon, Celine, et al.
Publicado: (2022)

Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura
por: Laghmouchi, Aicha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h1mhufklqk498taelds1h7casc